LMO2 and gene therapy for severe combined immunodeficiency.
Stone
Bryan D
BD
D000243:Adenosine Deaminase / Q000172:deficiency*; D001402:B-Lymphocytes; D040181:Genetic Diseases, X-Linked / Q000276:immunology / Q000628:therapy; D015316:Genetic Therapy; D006801:Humans; D007694:Killer Cells, Natural; D010641:Phenotype; D018123:Receptors, Interleukin / Q000276:immunology; D016511:Severe Combined Immunodeficiency / Q000276:immunology* / Q000628:therapy; D013601:T-Lymphocytes
D018123:Receptors, Interleukin; D000243:Adenosine Deaminase